BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study

Triple-negative breast cancer (TNBC) has several subtypes. The identification of markers associated with recurrence and poor prognosis in patients with TNBC is urgently needed. BRCAness is a set of traits in which <i>BRCA1</i> dysfunction, arising from gene mutation, methylation, or deletion, result...

Description complète

Détails bibliographiques

Auteurs principaux:	Yoshimasa Kosaka, Yutaka Yamamoto, Hirokazu Tanino, Hiroshi Nishimiya, Mutsuko Yamamoto-Ibusuki, Yuko Hirota, Hirotaka Iwase, Seigo Nakamura, Sadako Akashi-Tanaka
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2020-02-01
Collection:	Diagnostics
Sujets:	breast cancer brcaness triple-negative breast cancer neoadjuvant chemotherapy prognosis
Accès en ligne:	https://www.mdpi.com/2075-4418/10/2/119
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!